A Pilot Study to Evaluate the Safety and Immunogenicity of Low Dose Flu Vaccines

NCT00558649 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human

Interventions

BIOLOGICAL: Flu Vaccine (FLUARIX®)

Sponsor

NanoPass Technologies Ltd